| Code | 07945 | ||||||||||
| MA number | 68/0052/11-S | ||||||||||
| Product Form: | tbl flm 20x200 mg (blis.PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Accord Healthcare Polska Sp. z o.o., Poland | ||||||||||
| Therapeutic Class: | 68 - ANTIPSYCHOTICA (NEUROLEPTICA) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 30 | ||||||||||
| Container: | blister PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 16.05.2011 |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Quetiapine Accord tbl flm_09_2024.pdf
|
| Dokument: |
Quetiapine Accord_Prirucka pre zdravotnickych pracovnikov.pdf
|
| PIL: |
PIL_Quetiapine Accord tbl flm_04_2025.pdf
|
| Safety feature | Yes |
| Data update: | 08.01.2019 |
